分组1 - Fortrea Holdings Inc. reported quarterly earnings of $0.02 per share, exceeding the Zacks Consensus Estimate of a loss of $0.07 per share, and showing improvement from a loss of $0.04 per share a year ago, resulting in an earnings surprise of 128.57% [1] - The company posted revenues of $651.3 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 6.79%, although this represents a decline from year-ago revenues of $662.1 million [2] - Fortrea Holdings Inc. has underperformed the market, with shares losing about 67% since the beginning of the year compared to the S&P 500's decline of -3.8% [3] 分组2 - The current consensus EPS estimate for the coming quarter is $0.03 on revenues of $610.26 million, and for the current fiscal year, it is $0.39 on revenues of $2.47 billion [7] - The Zacks Industry Rank for Medical - Biomedical and Genetics is in the top 34% of over 250 Zacks industries, indicating that the industry outlook can significantly impact stock performance [8]
Fortrea Holdings Inc. (FTRE) Q1 Earnings and Revenues Beat Estimates